Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment

RecruitingOBSERVATIONAL

Enrollment

125

Participants

Timeline

Start Date

September 16, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 31, 2025

Conditions

Breast Cancer FemaleStage II Breast CancerStage III Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer

Trial Locations (3)

RECRUITING

MRCCC Siloam Hospitals Semanggi, Jakarta

RECRUITING

Medical Genetics Institute, Ho Chi Minh City

RECRUITING

University Medical Center HCMC, Ho Chi Minh City